AbbVie: A Dividend Fortress At An Appealing Price Tag
Apogee Therapeutics Inc APGE
$134.09
▼ -0.16%
($-0.21)
📈 Near 52W High
⬇️ Below Yest. Low
🗓️ Earnings Next Week
Open
$134.25
Prev Close
$134.30
Day Range
$134.05 – $134.35
52W Range
$34.34 – $134.46
Market Cap
$10.11B
Beta
0.24
EPS (TTM)
$-4.33
📋 Company Profile
| Industry | Biotechnology |
| Country | US |
| Exchange | NASDAQ NMS - GLOBAL MARKET |
| Currency | USD |
| IPO Date | 2023-07-14 |
| Shares Out. | 75,360,000 |
| Website | apogeetherapeutics.com/ ↗ |
| Phone | 13026587581 |
| Employees | 261 |
| Net Income | -$74.1M |
| Free Cash Flow | -$235.4M |
| Total Assets | $1.29B |
| Total Liabilities | $37.9M |
| Equity | $1.26B |
About Apogee Therapeutics Inc
Apogee Therapeutics Inc is a clinical-stage biotechnology company engaged in advancing optimized, novel biologics with the potential for differentiated efficacy and dosing in the inflammatory and immunology (I&I) markets, including for the treatment of atopic dermatitis (AD), asthma, eosinophilic esophagitis (EoE), chronic obstructive pulmonary disease (COPD), and other I&I indications. . Its antibody programs are designed to overcome the limitations of existing therapies by targeting well-established mechanisms of action and incorporating antibody engineering to optimize half-life and other properties.
Apogee Therapeutics Inc is a publicly traded company under the ticker symbol APGE on the NASDAQ NMS - GLOBAL MARKET, operating in the Biotechnology industry. Quotes and metrics shown here are sourced from public market data and refreshed regularly.
📊 Analyst Ratings
21 analysts (2026-07-01)